Publicaciones (99) Publicaciones de Camilo Silva Frojan

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  3. Corrigendum: Increased levels of interleukin-36 in obesity and type 2 diabetes fuels adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages(Front. Immunol., (2022), 13, (832185), 10.3389/fimmu.2022.832185)

    Frontiers in Immunology

  4. Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e145-e154

  5. Evaluation of Dietary and Alcohol Drinking Patterns in Patients with Excess Body Weight in a Spanish Cohort: Impact on Cardiometabolic Risk Factors

    Nutrients, Vol. 15, Núm. 22

  6. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. Changes in mechanical properties of adipose tissue after bariatric surgery driven by extracellular matrix remodelling and neovascularization are associated with metabolic improvements

    Acta Biomaterialia, Vol. 141, pp. 264-279

  2. Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  3. Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown

    Nutrients, Vol. 14, Núm. 13

  4. Netrin-1 Promotes Visceral Adipose Tissue Inflammation in Obesity and Is Associated with Insulin Resistance

    Nutrients, Vol. 14, Núm. 20

  5. ‘Obesities’: Position statement on a complex disease entity with multifaceted drivers

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

2021

  1. Decreased levels of microfibril‐associated glycoprotein (Magp)‐1 in patients with colon cancer and obesity are associated with changes in extracellular matrix remodelling

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  2. FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes

    Cellular and Molecular Immunology, Vol. 18, Núm. 10, pp. 2457-2459

  3. NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling

    Cellular and Molecular Immunology, Vol. 18, Núm. 4, pp. 1045-1057

  4. Resting energy expenditure is not altered in children and adolescents with obesity. Effect of age and gender and association with serum Leptin levels

    Nutrients, Vol. 13, Núm. 4

  5. Role of ANGPTL8 in NAFLD improvement after bariatric surgery in experimental and human obesity

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

  6. The differential expression of the inflammasomes in adipose tissue and colon influences the development of colon cancer in a context of obesity by regulating intestinal inflammation

    Journal of Inflammation Research, Vol. 14, pp. 6431-6446

2020

  1. Aquaporin-11 Contributes to TGF-β1-Induced Endoplasmic Reticulum Stress in Human Visceral Adipocytes: Role in Obesity-Associated Inflammation

    Cells, Vol. 9, Núm. 6

  2. Dermatopontin, a novel adipokine promoting adipose tissue extracellular matrix remodelling and inflammation in obesity

    Journal of Clinical Medicine, Vol. 9, Núm. 4